NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BaseLaunch

BaseLaunch

Overview

BaseLaunch is a Basel-based biotech incubator and accelerator that partners with scientists and entrepreneurs to help launch and grow early-stage ventures developing cutting-edge therapeutics.

Year Founded

2017

Portfolio Companies

17

Investments

BaseLaunch investments
CompanyDateStageLead
CancentusApr 2026AcceleratorLead
IlonovMar 2025AcceleratorCo-investor
NXI TherapeuticsJun 2024Pre SeedCo-investor
Versameb AGJul 2023VC RoundCo-investor
Engimmune TherapeuticsMay 2022SeedCo-investor

Key People

Stephan Emmerth

Director Business Development & Operations

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBasel
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.